Write up in AFR

Nice write up in the AFR today .... I think it is the first time they have given any prominence to the possible application of Volpara's software for lung screening as well. While this has been bubbling away in the background for a while and is probably not imminent it does indicate another very significant potential source of revenue. My understanding is that it could be offered through the same server they have already installed in radiology centers where the breast product is installed and that should make the sale process much easier. In the long run that link in to the radiology units could become very important to Volpara .... if you are a new company offering an analytical or diagnostic software product it might make more sense to partner with Volpara and use their infrastructure rather than try to replicate it from scratch. In essence this is the deal they are looking to do with Screen Point and it shows the value in this model as Volpara will take a share of the revenue generated.